admin, Author at PsyNews.com

Home Authors Posts by admin

2161 POSTS 0 COMMENTS

https://psynews.com

Pα+ Psychedelic Bulletin #178: VA Funding of Lykos Phase 3 ‘Definitely...

Meet the Legal Team Fighting the DEA to Save Psychedelic Research

What You Need to Know About Massachusetts’ Question 4 and the...

Psychedelics Take Centre Stage in Massachusetts’ Local Media

Psychedelic Education Through a Healing Justice Lens

Pα+ Psychedelic Bulletin #177: Bright Minds Surges on Longboard’s Seizure Drug...

How Shadow Work Can Be a Powerful Tool for Psychedelic Transformation

The FDA, MDMA, and Public Perception: Was the FDA Fair to...

Pα+ Psychedelic Bulletin #176: Drug Developers Discuss Trial Design; Massachusetts Vote...

Protecting Indigenous Wisdom: Rethinking Psychedelic Legalization

1...567...217 Page 6 of 217

Natural Medicine Advisory Bulletin 15: A Duplicitous December

Pot for the People: Debunking Cannabis Myths and Empowering Consumers

How Psychedelics Can Help Build a Better You: The Power in...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin